Akihiro Kurimasa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Akihiro Kurimasa has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Kazuo Tomita
Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
8 shared publications - Kento Igarashi
Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
8 shared publications - Tomoaki Sato
Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
8 shared publications - Nobue Kitanaka
Laboratory of Drug Addiction and Experimental Therapeutics, Department of Pharmacy, School of Pharmacy, Hyogo Medical University, Kobe, Japan
4 shared publications Yoshihiro Nishitani
Department of Restorative Dentistry and Endodontology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan
4 shared publicationsYoshikazu Kuwahara
Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, 890-8544, Japan; Division of Radiation Biology and Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, 983-8536, Japan
4 shared publications
Latest Publications
- Open Access
- 23 April 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 766, 151888
Amoxicillin, a β-lactam antibiotic, enhances cisplatin sensitivity in cancer cells affecting mitochondria
- 23 April 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 766, 151888
Open AccessAmoxicillin, a β-lactam antibiotic, enhances cisplatin sensitivity in cancer cells affecting mitochondria
- Open Access
- 2 December 2024
- Published by Springer Nature in BioNanoScience
- Vol. 15 (1) , 1-11
Silver Nanoparticles Reduce ACE2 Expression via Changing Mitochondrial Function in Human Fibroblast-Like Lung Cell and Periodontal Ligament Fibroblast Cells
- 2 December 2024
- Published by Springer Nature in BioNanoScience
- Vol. 15 (1) , 1-11
Open AccessSilver Nanoparticles Reduce ACE2 Expression via Changing Mitochondrial Function in Human Fibroblast-Like Lung Cell and Periodontal Ligament Fibroblast Cells
- Open Access
- 11 November 2023
- Published by Elsevier in Japanese Dental Science Review
- Vol. 59, 431-438
Therapeutic potential for KCC2-targeted neurological diseases
- 11 November 2023
- Published by Elsevier in Japanese Dental Science Review
- Vol. 59, 431-438
Open AccessTherapeutic potential for KCC2-targeted neurological diseases
- Open Access
- 12 November 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 637, 286-293
Dynamic imaging analysis reveals Auger electron-emitting radio-cisplatin induces DNA damage depending on the cell cycle
- 12 November 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 637, 286-293
Open AccessDynamic imaging analysis reveals Auger electron-emitting radio-cisplatin induces DNA damage depending on the cell cycle
- Open Access
Mitochondrial Dysfunction in Diseases, Longevity, and Treatment Resistance: Tuning Mitochondria Function as a Therapeutic Strategy
Mitochondria are very important intracellular organelles because they have various functions. They produce ATP, are involved in cell signaling and cell death, and are a major source of reactive oxygen species (ROS). Mitochondria have their own DNA (mtDNA) and mutation of mtDNA or change the mtDNA copy numbers leads to disease, cancer chemo/radioresistance and aging including longevity. In this review, we discuss the mtDNA mutation, mitochondrial disease, longevity, and importance of mitochondrial dysfunction in cancer first. In the later part, we particularly focus on the role in cancer resistance and the mitochondrial condition such as mtDNA copy number, mitochondrial membrane potential, ROS levels, and ATP production. We suggest a therapeutic strategy employing mitochondrial transplantation (mtTP) for treatment-resistant cancer.
Open AccessMitochondrial Dysfunction in Diseases, Longevity, and Treatment Resistance: Tuning Mitochondria Function as a Therapeutic Strategy
Mitochondria are very important intracellular organelles because they have various functions. They produce ATP, are involved in cell signaling and cell death, and are a major source of reactive oxygen species (ROS). Mitochondria have their own DNA (mtDNA) and mutation of mtDNA or change the mtDNA copy numbers leads to disease, cancer chemo/radioresistance and aging including longevity. In this review, we discuss the mtDNA mutation, mitochondrial disease, longevity, and importance of mitochondrial dysfunction in cancer first. In the later part, we particularly focus on the role in cancer resistance and the mitochondrial condition such as mtDNA copy number, mitochondrial membrane potential, ROS levels, and ATP production. We suggest a therapeutic strategy employing mitochondrial transplantation (mtTP) for treatment-resistant cancer.
- Open Access
- 2 August 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (15) , 8300
MiR-7-5p Is Involved in Ferroptosis Signaling and Radioresistance Thru the Generation of ROS in Radioresistant HeLa and SAS Cell Lines
In cancer therapy, radioresistance or chemoresistance cells are major problems. We established clinically relevant radioresistant (CRR) cells that can survive over 30 days after 2 Gy/day X-ray exposures. These cells also show resistance to anticancer agents and hydrogen peroxide (H2O2). We have previously demonstrated that all the CRR cells examined had up-regulated miR-7-5p and after miR-7-5p knockdown, they lost radioresistance. However, the mechanism of losing radioresistance remains to be elucidated. Therefore, we investigated the role of miR-7-5p in radioresistance by knockdown of miR-7-5p using CRR cells. As a result, knockdown of miR-7-5p increased reactive oxygen species (ROS), mitochondrial membrane potential, and intracellular Fe2+ amount. Furthermore, miR-7-5p knockdown results in the down-regulation of the iron storage gene expression such as ferritin, up-regulation of the ferroptosis marker ALOX12 gene expression, and increases of Liperfluo amount. H2O2 treatment after ALOX12 overexpression led to the enhancement of intracellular H2O2 amount and lipid peroxidation. By contrast, miR-7-5p knockdown seemed not to be involved in COX-2 and glycolysis signaling but affected the morphology of CRR cells. These results indicate that miR-7-5p control radioresistance via ROS generation that leads to ferroptosis.
- 2 August 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (15) , 8300
Open AccessMiR-7-5p Is Involved in Ferroptosis Signaling and Radioresistance Thru the Generation of ROS in Radioresistant HeLa and SAS Cell Lines
In cancer therapy, radioresistance or chemoresistance cells are major problems. We established clinically relevant radioresistant (CRR) cells that can survive over 30 days after 2 Gy/day X-ray exposures. These cells also show resistance to anticancer agents and hydrogen peroxide (H2O2). We have previously demonstrated that all the CRR cells examined had up-regulated miR-7-5p and after miR-7-5p knockdown, they lost radioresistance. However, the mechanism of losing radioresistance remains to be elucidated. Therefore, we investigated the role of miR-7-5p in radioresistance by knockdown of miR-7-5p using CRR cells. As a result, knockdown of miR-7-5p increased reactive oxygen species (ROS), mitochondrial membrane potential, and intracellular Fe2+ amount. Furthermore, miR-7-5p knockdown results in the down-regulation of the iron storage gene expression such as ferritin, up-regulation of the ferroptosis marker ALOX12 gene expression, and increases of Liperfluo amount. H2O2 treatment after ALOX12 overexpression led to the enhancement of intracellular H2O2 amount and lipid peroxidation. By contrast, miR-7-5p knockdown seemed not to be involved in COX-2 and glycolysis signaling but affected the morphology of CRR cells. These results indicate that miR-7-5p control radioresistance via ROS generation that leads to ferroptosis.
- Open Access
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 3-108
Involvement of intracellular Fe2+ against oxidative stress in CRR cells
To achieve more effective cancer treatment, we have established and analyzed "clinically relevant radioresistant (CRR) cells" that can survive exposing to 2 Gy/day X-rays for more than 30 days. CRR cells show resistance against hydrogen peroxide (H2O2) that is one of the reactive oxygen species. However, the resistant mechanism to H2O2 has not been elucidated yet. Therefore, we investigated the involvement of iron ion in the resistant mechanism to H2O2 in CRR cells because iron ion has been reported to react with H2O2 and produce hydroxyl radical (・OH). ・OH have been shown to react with plasma membrane phospholipid and lead to cell death. Internal Fe2+ and ・OH amount were decreased in CRR cells compared with its parental cells. In addition, expression of ferritin, which is iron-binding protein, was increased in CRR cells. No internal H2O2 increase and no lipid peroxidation were seen in CRR cells after 50 µM H2O2 treatment for 2 hours, whereas internal H2O2 uptake and lipid peroxidation was increased after 50 µM H2O2 treatment for 2 hours in parental cells. Furthermore, Pretreatment of 10 µM of FeCl2 leads to more cell death after administration of 50 µM H2O2 in CRR cells. Administration of phospholipid also led to further cell death after 50 µM H2O2 treatment in CRR cells. These results suggest that intracellular Fe2+ content is very important against oxidative stress response in CRR cells and control of Fe2+ amount may be an effective option for cancer that is resistant to treatment.
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 3-108
Open AccessInvolvement of intracellular Fe2+ against oxidative stress in CRR cells
To achieve more effective cancer treatment, we have established and analyzed "clinically relevant radioresistant (CRR) cells" that can survive exposing to 2 Gy/day X-rays for more than 30 days. CRR cells show resistance against hydrogen peroxide (H2O2) that is one of the reactive oxygen species. However, the resistant mechanism to H2O2 has not been elucidated yet. Therefore, we investigated the involvement of iron ion in the resistant mechanism to H2O2 in CRR cells because iron ion has been reported to react with H2O2 and produce hydroxyl radical (・OH). ・OH have been shown to react with plasma membrane phospholipid and lead to cell death. Internal Fe2+ and ・OH amount were decreased in CRR cells compared with its parental cells. In addition, expression of ferritin, which is iron-binding protein, was increased in CRR cells. No internal H2O2 increase and no lipid peroxidation were seen in CRR cells after 50 µM H2O2 treatment for 2 hours, whereas internal H2O2 uptake and lipid peroxidation was increased after 50 µM H2O2 treatment for 2 hours in parental cells. Furthermore, Pretreatment of 10 µM of FeCl2 leads to more cell death after administration of 50 µM H2O2 in CRR cells. Administration of phospholipid also led to further cell death after 50 µM H2O2 treatment in CRR cells. These results suggest that intracellular Fe2+ content is very important against oxidative stress response in CRR cells and control of Fe2+ amount may be an effective option for cancer that is resistant to treatment.
- Open Access
- 1 October 2018
- Published by Elsevier in Data in Brief
- Vol. 20, 402-410
Data on the aquaporin gene expression differences among ρ0, clinically relevant radioresistant, and the parental cells of human cervical cancer and human tongue squamous cell carcinoma
- 1 October 2018
- Published by Elsevier in Data in Brief
- Vol. 20, 402-410
Open AccessData on the aquaporin gene expression differences among ρ0, clinically relevant radioresistant, and the parental cells of human cervical cancer and human tongue squamous cell carcinoma
- Open Access
- 1 August 2018
- Published by SAGE Publications in Tumor Biology
- Vol. 40 (9)
Clinically relevant radioresistant cells exhibit resistance to H2O2 by decreasing internal H2O2 and lipid peroxidation
Radiation therapy is one of the choices to treat malignant tumors. In radiation therapy, existence of radiation-resistant cell is a major problem to overcome. We established clinically relevant radioresistant cells that had been obtained by exposing to 2 Gy/day X-rays for more than 30 days. These cells are resistant to 2 Gy/day X-ray exposure and anticancer agents. However, the underlying resistance mechanism remains unclear. We investigated the resistance of clinically relevant radioresistant cells to hydrogen peroxide (H2O2), confirming a degree of resistance. Neither catalase enzyme activity nor aquaporins appeared to be involved in H2O2 resistance. Mitochondrial DNA copy number, adenosine triphosphate (ATP) concentration, and plasma membrane potential were decreased. The timing of H2O2 intake was delayed and lipid peroxidation was decreased. Sensitivity of clinically relevant radioresistant cells to H2O2 was enhanced by 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine administration. These results suggest that the membrane status is a major factor conferring H2O2 resistance in clinically relevant radioresistant cells, and we should further investigate how membrane status could be used to enhance the therapeutic effect on cancer.
- 1 August 2018
- Published by SAGE Publications in Tumor Biology
- Vol. 40 (9)
Open AccessClinically relevant radioresistant cells exhibit resistance to H2O2 by decreasing internal H2O2 and lipid peroxidation
Radiation therapy is one of the choices to treat malignant tumors. In radiation therapy, existence of radiation-resistant cell is a major problem to overcome. We established clinically relevant radioresistant cells that had been obtained by exposing to 2 Gy/day X-rays for more than 30 days. These cells are resistant to 2 Gy/day X-ray exposure and anticancer agents. However, the underlying resistance mechanism remains unclear. We investigated the resistance of clinically relevant radioresistant cells to hydrogen peroxide (H2O2), confirming a degree of resistance. Neither catalase enzyme activity nor aquaporins appeared to be involved in H2O2 resistance. Mitochondrial DNA copy number, adenosine triphosphate (ATP) concentration, and plasma membrane potential were decreased. The timing of H2O2 intake was delayed and lipid peroxidation was decreased. Sensitivity of clinically relevant radioresistant cells to H2O2 was enhanced by 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine administration. These results suggest that the membrane status is a major factor conferring H2O2 resistance in clinically relevant radioresistant cells, and we should further investigate how membrane status could be used to enhance the therapeutic effect on cancer.